AA, B., M, C., MJ, S., RR, M., JC, A., & J, C. (2013). In vitro evaluation of guanidine analogs as sigma receptor ligands for potential anti-stroke therapeutics. The Journal of pharmacology and experimental therapeutics, 344(1), 155. https://doi.org/10.1124/jpet.112.199513
Chicago Style (17th ed.) CitationAA, Behensky, Cortes-Salva M, Seminerio MJ, Matsumoto RR, Antilla JC, and Cuevas J. "In Vitro Evaluation of Guanidine Analogs as Sigma Receptor Ligands for Potential Anti-stroke Therapeutics." The Journal of Pharmacology and Experimental Therapeutics 344, no. 1 (2013): 155. https://doi.org/10.1124/jpet.112.199513.
MLA (9th ed.) CitationAA, Behensky, et al. "In Vitro Evaluation of Guanidine Analogs as Sigma Receptor Ligands for Potential Anti-stroke Therapeutics." The Journal of Pharmacology and Experimental Therapeutics, vol. 344, no. 1, 2013, p. 155, https://doi.org/10.1124/jpet.112.199513.